Results 151 to 160 of about 8,269 (200)

CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia. [PDF]

open access: yesBlood Cancer J
Fathima S   +19 more
europepmc   +1 more source

One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol. [PDF]

open access: yesBlood Cancer J
Yousuf M   +17 more
europepmc   +1 more source

Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia. [PDF]

open access: yesJ Clin Oncol
Lanino L   +50 more
europepmc   +1 more source

Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.

open access: yesActa Haematol
Abdulgayoom M   +7 more
europepmc   +1 more source

Mouse Models of CMML [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Chronic myelomonocytic leukemia (CMML) is a rare and challenging type of myeloproliferative neoplasm. Poor prognosis and high mortality, associated predominantly with progression to secondary acute myeloid leukemia (sAML), is still an unsolved problem ...
Ekaterina Belotserkovskaya   +1 more
exaly   +4 more sources

Oligo-Monocytic CMML and Other Pre-CMML States: Clinical Impact, Prognostication and Management

Best Practice and Research in Clinical Haematology, 2020
Chronic myelomonocytic leukemia (CMML) is defined by myelodysplasia, pathologic accumulation of monocytes and a substantial risk to transform to secondary acute myeloid leukemia (sAML). In recent years, minimal diagnostic criteria for classical CMML and CMML-variants were proposed.
Peter Valent
exaly   +3 more sources

Characterization of CMML with Normal Karyotype in Comparison to CMML with Aberrant Karyotype

Blood, 2015
Abstract Background: CMML is a myelodysplastic/myeloproliferative neoplasm with distinct morphological and genetic features. Based on differences in blast count CMML is divided into CMML-1 (<1% blasts in the peripheral blood (pB) and <10% in the bone marrow (BM)) and CMML-2 (5-19% blasts in pB, 10-19% in BM or presence of Auer rods)
Claudia Haferlach   +4 more
openaire   +1 more source

CMML: Clinical and molecular aspects

International Journal of Hematology, 2017
Chronic Myelomonocytic Leukemia is a chronic myeloid neoplasm occurring mostly in the elderly with overlapping features of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) characterized by chronic monocytosis. Recent progresses in the molecular and cellular pathogenesis of CMML have stirred a renewed interest in this clinically ...
Raphael, Itzykson   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy